The Discounted Cash Flow (DCF) valuation of ABIOMED Inc (ABMD) is 134.56 USD. With the latest stock price at 381.02 USD, the upside of ABIOMED Inc based on DCF is -64.7%.
Based on the latest price of 381.02 USD and our DCF valuation, ABIOMED Inc (ABMD) is a sell. selling Abiomed stocks now will result in a potential gain of 64.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.3% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 84.34 - 385.07 | 134.56 |
| Upside | -77.9% - 1.1% | -64.7% |